Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Dipl.Biochem.
2023
2023
2023
2023
2023
2014
2020
Interest in early investment opportunities in immuno-oncology, regenerative medicine and anti-infectives. (Please describe scope of interaction in contact requests. Thank you!)
2018 - 2020
Project leadership for global drug development projects
2014 - 2018
Head of Bioanalysis/DMPK Biosimilar Programs Heading of non-clinical activities for Biosimilars Portfolio Serving as Head of Nonclinical for Biosimilar projects Pharmacology / Toxicology activities for the Biosimilars Business
2013 - 2014
Pharmacokinetics of monoclonal antibodies (biosimilarity trials, population PK) Responsibility for Bionalysis/DMPK (PK, ADA, nAb assays) Pharmacology of monoclonal antibodies (SPR, CDC, ADCC, effector functions, FcR, glycosylation) Immunogenicity Toxicological studies Translational research/devlopment Regulatory agenciy interactions
2020 - 2021
2020 - 2021
2008 - 2013
2008 - 2013
Associate Director Pharmacology Biotherapeutics. Expertise Preclinical Development, Immunology, ICH Guidelines, IMPD/IND preparation, Toxicology, PK/PD, Project management, Monoclonal Antibodies, Biotherapeutics, Flowcytometrie, Research Tregs, Collaboration Management.
2003 - 2007
2003 - 2007
Scientist Immunology Basic Research Dendritic cells, T cells, Tregs, B cells, Cell Trafficking, S1P signalling. Expertise FACS, cell sorting, Immunofluorescence, Antibody production, labelling.basic immunology, RT-PCR.